红星资本局12月10日消息,近日,国家医保局发布2025年《国家基本医疗保险、生育保险和工伤保险药品目录》,礼来(LLY.N)GIP/GLP-1 RA双靶点降糖药,替尔泊肽注射液(商品名:穆峰达)获纳入,医保覆盖范围适用于成人2型糖尿病患者的血糖控制。近年来,新型降糖药物GLP-1RA(胰高血糖素样肽-1受体激动剂)受到广泛关注,国内赛道竞争也日益激烈。礼来新“药王”首次纳入国家医保另有2款国产...
Source Link红星资本局12月10日消息,近日,国家医保局发布2025年《国家基本医疗保险、生育保险和工伤保险药品目录》,礼来(LLY.N)GIP/GLP-1 RA双靶点降糖药,替尔泊肽注射液(商品名:穆峰达)获纳入,医保覆盖范围适用于成人2型糖尿病患者的血糖控制。近年来,新型降糖药物GLP-1RA(胰高血糖素样肽-1受体激动剂)受到广泛关注,国内赛道竞争也日益激烈。礼来新“药王”首次纳入国家医保另有2款国产...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.